GGrantIndex
Sort

64,565 grants matching drug discovery

NEW ANTICANCER DRUGS FOR CULTURED AND COLLECTED MARINE O

$653,975
University Of California San Diego · U19 · FY2002 · CA

BU-CMD Chemical Library Consortium: Fostering Collaborations between Chemists and Biologists for Translational Discovery

$653,898
John A Porco · Boston University (Charles River Campus) · U01 · FY2022 · TR

BU-CMD Chemical Library Consortium: Fostering Collaborations between Chemists and Biologists for Translational Discovery

$653,898
John A Porco · Boston University (Charles River Campus) · U01 · FY2023 · TR

The Role of Pdcd4 in Translation, Tumorigenesis and Tumor Progression

$653,846
Nancy H. Colburn · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

The Role of AP-1 and Other Transcription Factors in Cancer Cause and Prevention

$653,846
Nancy H. Colburn · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Identification of new inhibitors of essential functions in M. tuberculosis by high-throughput metabolic profiling

$653,812
Michael Berney · Albert Einstein College Of Medicine · R01 · FY2023 · AI

Discovery of functionally selective Alzheimer's disease therapeutics

$653,795
John A Schetz · University Of North Texas Hlth Sci Ctr · R01 · FY2017 · AG

The Alzheimer's Disease Resiliome: Pathway Analysis and Drug Discovery.

$653,770
Rudolph Emile Tanzi · Massachusetts General Hospital · R01 · FY2023 · AG

Epigenetic Determinants Influencing Development and Evolution of Chronic Post-surgical Pain in Children Undergoing Musculoskeletal Surgery.

$653,767
Vidya Chidambaran · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · AR

Genetic and Functional Analysis of Rapid Renal Decline in Diabetes: A Family-based Approach to Accelerate Gene Discovery

$653,765
Marcus Guy Pezzolesi · University Of Utah · R01 · FY2022 · DK

Roles of Noncoding RNA in Bone Regeneration

$653,701
Jake Jinkun Chen · Tufts University Boston · R01 · FY2020 · DE

Hematalogical Malignancies

$653,591
Richard James Gilbertson · St. Jude Children'S Research Hospital · P30 · FY2014 · CA

Development and validation of a novel 3D human in vitro model of nonalcoholic steatohepatitis to be used for novel therapeutic screening and research on disease mechanism.

$653,558
Jeffrey N. Miner · Organovo, Inc. · R44 · FY2019 · DK

Catalytic Redox Reactions for Pharmaceutical Synthesis

$653,553
Shannon S Stahl · University Of Wisconsin-Madison · R35 · FY2025 · GM

Network Medicine and Systems Pharmacology to Advance Precision Medicine in Combined Pulmonary Hypertension

$653,505
Evan L Brittain · Vanderbilt University Medical Center · R01 · FY2023 · HL

Chemical biology of Peptide Regulation of Opioid Receptor Function

$653,447
Carrie Haskell-Luevano · University Of Minnesota · R01 · FY2021 · DA

Characterization of novel insulin resistance genes by gene editing, high-throughput phenotyping and in vivo studies

$653,400
Joshua Wiley Knowles · Stanford University · R01 · FY2019 · DK

Project 1: Systematic discovery of cell-intrinsic mechanisms of cancer drug resistance

$653,390
Scott R Manalis · Massachusetts Institute Of Technology · U54 · FY2017 · CA

Drug Dependence Clinical Research Program-Research Support Core

$653,387
Reese T. Jones · University Of California, San Francisco · P30 · FY2015 · DA

African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translation

$653,336
Minoli A Perera · Northwestern University At Chicago · U54 · FY2020 · MD

Quantitative Structural and Functional Imaging of the Lung

$653,301
Rahim R Rizi · University Of Pennsylvania · R01 · FY2008 · HL

REGULATION OF LIPID METABOLISM IN BACTERIA

$653,244
Charles O Rock · St. Jude Children'S Research Hospital · R37 · FY2009 · GM

Predicting Brain Changes in HIV/AIDS

$653,228
Paul M Thompson · University Of California Los Angeles · R01 · FY2012 · NS

The development of a recombinant vaccine against human onchocerciasis

$653,219
Sara Lustigman · New York Blood Center · R01 · FY2012 · AI

Chromatin regions, genes and pathways that confer susceptibility to chemical-induced DNA damage

$653,211
Ivan Rusyn · Texas A&M Agrilife Research · R01 · FY2023 · ES